Sartorius Stedim Biotech SA (STDM)

Paris


	Symbol		Exchange		Currency
	STDM		Paris		EUR	Real-time
	DIMp		BATS Europe		EUR	Delayed
	56S1		Frankfurt		EUR	Delayed
	DIM		Vienna		EUR	Real-time

Currency in EUR

179.80

+4.55(+2.60%)

Closed06/12

Fair Value

Day's Range

175.00

180.20

52 wk Range

139.10

281.00

Sartorius Stedim (STDM) Income Statement & Profits

Assess the Sartorius Stedim Income Statement (earnings report), showing the company's financial performance from operating and non operating activities such as revenue, expenses and income. Check assets and liabilities, diluted earnings per share (EPS), and net income after taxes for the last 4 periods (either quarterly or annually).

Investors who need greater depth or who want to customise how data is presented to fit their own investment styles are able to do so via their very own InvestingPro account.

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

1,440.57

1,910.08

2,887

3,492.7

2,775.5

Total Revenues Growth

+18.84%

+32.59%

+51.15%

+20.98%

-20.53%

Cost Of Revenues

692.28

906.76

1,334

1,675.4

1,542

Gross Profit

748.29

1,003.32

1,553

1,817.3

1,233.5

Gross Profit Growth

+18.86%

+34.08%

+54.79%

+17.02%

-32.12%

Gross Profit Margin %

51.94%

52.53%

53.79%

52.03%

44.44%

Other Operating Expenses, Total

400.39

500.19

632.8

762.9

764.8

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+16.84%	+24.93%	+26.51%	+20.56%	+0.25%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	79.22	84.45	110.5	132.4	129.5
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	317.63	391.85	531.9	612.3	617.8
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	3.54	23.89	-9.6	18.2	17.5

Operating Income

347.9

503.14

920.2

1,054.4

468.7

Operating Income Growth

+21.27%

+44.62%

+82.89%

+14.58%

-55.55%

EBIT Margin %

24.15%

26.34%

31.87%

30.19%

16.89%

Net Interest Expenses

-3.53

-6

-9.9

-17.7

-109.2

Net Interest Expenses Growth

-19.23%

-70.07%

-65%

-78.79%

-516.95%

Interest Expense, Total

-3.86

-6.51

-10.2

-18.2

-115.4

Interest And Investment Income

0.34

0.51

0.3

0.5

6.2

Other Non Operating Expenses, Total

-10.14

-13.58

-24.8

-37.4

-18

EBT, Excl. Unusual Items

334.23

483.55

885.5

999.3

341.5

Gain (Loss) On Sale Of Assets

-

-

-

-

-

Other Unusual Items, Total

-16.51

-18.56

-218.5

131.1

59.6

EBT, Incl. Unusual Items

317.42

460.69

646.7

1,130.4

401.1

EBT, Incl. Unusual Items Growth

+11.55%

+45.14%

+40.38%

+74.8%

-64.52%

EBT, Incl. Unusual Items Margin

22.03%

24.12%

22.4%

32.36%

14.45%

Income Tax Expense

81.38

122.1

232.4

250.5

89

Net Income to Company

236.04

338.6

414.3

879.9

312.1

Minority Interest

-1.54

-2.67

0.1

-3.8

-2.4

Net Income

234.5

335.93

414.4

876.1

309.7

Net Income Growth

+12.71%

+43.25%

+23.36%

+111.41%

-64.65%

Net Income Margin %

16.28%

17.59%

14.35%

25.08%

11.16%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

234.5

335.93

414.4

876.1

309.7

Basic EPS - Continuing Operations

2.54

3.64

4.5

9.51

3.36

Basic EPS - Continuing Operations Growth

+12.71%

+43.25%

+23.36%

+111.45%

-64.65%

Diluted EPS - Continuing Operations

2.54

3.64

4.5

9.51

3.36

Diluted EPS - Continuing Operations Growth

+12.53%

+43.31%

+23.51%

+111.45%

-64.65%

Basic Weighted Average Shares Outstanding

92.18

92.18

92.18

92.16

92.16

Diluted Weighted Average Shares Outstanding

92.18

92.18

92.18

92.16

92.16

Dividend Per Share

0.34

0.68

1.26

1.44

0.69

Dividend Per Share Growth

-40.35%

+100%

+85.29%

+14.29%

-52.08%

EBITDA

401.54

577.32

1,031.4

1,196.9

657.8

EBITDA Growth

+17.41%

+43.78%

+78.65%

+16.05%

-45.04%

EBITDA Margin %